Therapeutic-dose anticoagulation reduces mortality risk compared with prophylactic-dose anticoagulation in patients hospitalized for COVID-19
1. In this meta-analysis of randomized trials involving patients hospitalized with COVID-19, therapeutic-dose anticoagulation was found to be associated with ...
![siRNA against antithrombin alleviates symptoms of hemophilia [PreClinical]](https://www.2minutemedicine.com/wp-content/uploads/2015/04/clot-CCWiki-350x250.jpg)

